VR 160/20
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VR 160/20, covering 2013-08-07 to 2013-08-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg [Phase 1]